Product Description: NHS-MMAF is a modified MMAF extracted from patent WO2012143499, intermediat 219. MMAF is a potent tubulin polymerization inhibitor and is used as a antitumor agent[1]
Applications: Cancer-programmed cell death
Formula: C49H78N6O12
References: [1]WO2012143499
CAS Number: 1404073-19-3
Molecular Weight: 943.18
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: Drug-Linker Conjugates for ADC;Microtubule/Tubulin